__timestamp | Amphastar Pharmaceuticals, Inc. | Evotec SE |
---|---|---|
Wednesday, January 1, 2014 | 210461000 | 89496000 |
Thursday, January 1, 2015 | 251519000 | 127677000 |
Friday, January 1, 2016 | 255165000 | 164507000 |
Sunday, January 1, 2017 | 240175000 | 257630000 |
Monday, January 1, 2018 | 294666000 | 375405000 |
Tuesday, January 1, 2019 | 322357000 | 446437000 |
Wednesday, January 1, 2020 | 349846000 | 500924000 |
Friday, January 1, 2021 | 437768000 | 618034000 |
Saturday, January 1, 2022 | 498987000 | 751448000 |
Sunday, January 1, 2023 | 644395000 | 781426000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, revenue growth is a key indicator of success. Amphastar Pharmaceuticals, Inc. and Evotec SE have been on intriguing trajectories since 2014. Amphastar's revenue has surged by over 200%, from approximately $210 million in 2014 to an impressive $644 million in 2023. Meanwhile, Evotec SE has experienced a remarkable growth of nearly 800%, starting from a modest $89 million in 2014 and reaching $781 million by 2023.
Eli Lilly and Company vs Evotec SE: Annual Revenue Growth Compared
Revenue Insights: Pfizer Inc. and Amphastar Pharmaceuticals, Inc. Performance Compared
Who Generates More Revenue? Sanofi or Evotec SE
Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.: Examining Key Revenue Metrics
GSK plc vs Amphastar Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Bio-Techne Corporation vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Walgreens Boots Alliance, Inc. and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Exelixis, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Who Generates More Revenue? Halozyme Therapeutics, Inc. or Evotec SE
TG Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Dynavax Technologies Corporation vs Evotec SE: Annual Revenue Growth Compared
Comparing Revenue Performance: Taro Pharmaceutical Industries Ltd. or Evotec SE?